• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的长期预后:工作残疾:一项对823例患者进行的为期18年的前瞻性研究。

The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.

作者信息

Wolfe F, Hawley D J

机构信息

Arthritis Research Center and University of Kansas School of Medicine, Wichita 67214, USA.

出版信息

J Rheumatol. 1998 Nov;25(11):2108-17.

PMID:9818651
Abstract

OBJECTIVE

Work disability is a common outcome of rheumatoid arthritis (RA). Yet there have been no longitudinal, longterm, prospective studies of work disability in this illness. This 18 year longitudinal study investigates the rate of work disability, its concomitants, and its predictors, using a large series of clinical, laboratory, and self-report measures.

METHODS

In 1974, a computerized database was developed for the contemporaneous entry of all patient visits. Data included clinical, laboratory, and self-report information. Patients were also assessed by mailed questionnaires at 6 month intervals. In 1994, patients with RA were interviewed in detail about lifetime work status and work disability.

RESULTS

Work disability was estimated to occur in 25% at 6.4 years and 50% at 20.9 years after disease onset, and most disability occurred late in the course of disease. Work disability was predicted by almost every demographic and clinical variable. Education level, body mass index (BMI), erythrocyte sedimentation rate, rheumatoid factor, pain, Health Assessment Questionnaire (HAQ) disability, and physical demands of the job were independently associated with disability. Over the course of their illness, the work disabled had a 35% reduction in family income, and had more abnormal scores for joint counts, grip strength, sedimentation rate, pain, global severity, HAQ disability, and anxiety and depression. Except for BMI, the results were essentially similar in a subset of 156 patients seen first with a disease duration of less than one year.

CONCLUSION

Work disability can be predicted by patient and work characteristics present at the first clinic visit, but it is persistent abnormalities of sedimentation rate, HAQ disability, and pain, which may be detected in longitudinal followup, that best predict work disability after work and demographic characteristics are accounted for.

摘要

目的

工作能力丧失是类风湿关节炎(RA)的常见后果。然而,尚无针对该疾病工作能力丧失的纵向、长期、前瞻性研究。这项为期18年的纵向研究使用一系列临床、实验室和自我报告测量方法,调查工作能力丧失的发生率、伴随情况及其预测因素。

方法

1974年建立了一个计算机化数据库,用于同步录入所有患者就诊信息。数据包括临床、实验室和自我报告信息。患者还每隔6个月通过邮寄问卷进行评估。1994年,对类风湿关节炎患者就其一生的工作状况和工作能力丧失情况进行了详细访谈。

结果

据估计,发病后6.4年有25%的患者出现工作能力丧失,20.9年时有50%的患者出现工作能力丧失,且大多数工作能力丧失发生在病程后期。几乎每一个人口统计学和临床变量都可预测工作能力丧失。教育水平、体重指数(BMI)、红细胞沉降率、类风湿因子、疼痛、健康评估问卷(HAQ)残疾评分以及工作的体力要求与工作能力丧失独立相关。在患病过程中,工作能力丧失的患者家庭收入减少了35%,关节计数、握力、沉降率、疼痛、整体严重程度、HAQ残疾评分以及焦虑和抑郁方面的异常得分更高。除BMI外,在首次就诊时病程不到一年的156名患者亚组中,结果基本相似。

结论

首次就诊时患者的特征和工作特征可预测工作能力丧失,但在考虑工作和人口统计学特征后,沉降率、HAQ残疾评分和疼痛的持续异常(可在纵向随访中检测到)最能预测工作能力丧失。

相似文献

1
The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.类风湿关节炎的长期预后:工作残疾:一项对823例患者进行的为期18年的前瞻性研究。
J Rheumatol. 1998 Nov;25(11):2108-17.
2
A reappraisal of HAQ disability in rheumatoid arthritis.类风湿关节炎中健康评估问卷残疾程度的重新评估。
Arthritis Rheum. 2000 Dec;43(12):2751-61. doi: 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6.
3
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.工作残疾在 21 世纪仍是类风湿关节炎的一个主要问题:来自 QUEST-RA 研究的 32 个国家的数据。
Arthritis Res Ther. 2010;12(2):R42. doi: 10.1186/ar2951. Epub 2010 Mar 12.
4
Are patient self-report measures of arthritis activity confounded by mood? A longitudinal study of patients with rheumatoid arthritis.关节炎活动度的患者自我报告测量是否会受到情绪的干扰?一项对类风湿性关节炎患者的纵向研究。
J Rheumatol. 1994 Jun;21(6):1046-50.
5
Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.早期类风湿性关节炎患者的晨僵与功能残疾的关联比与关节肿胀及红细胞沉降率的关联更为密切。
J Rheumatol. 2004 Sep;31(9):1723-6.
6
The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis.类风湿关节炎的长期结局:一项对1600例类风湿关节炎患者进行的为期23年的全关节置换前瞻性纵向研究及其预测因素。
Arthritis Rheum. 1998 Jun;41(6):1072-82. doi: 10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G.
7
[A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].[一项多中心横断面研究,使用修订后的日语版关节炎影响测量量表第2版(AIMS 2)评估类风湿性关节炎患者的健康相关生活质量,重点关注医疗费用及其相关因素]
Ryumachi. 2002 Feb;42(1):23-39.
8
A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.对类风湿性关节炎患者进行的1986 - 1996年10年前瞻性随访。
J Rheumatol. 2001 Nov;28(11):2409-15.
9
Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?类风湿关节炎的临床指标:哪些对评估患者最有用?
J Rheumatol. 1994 Jan;21(1):17-27.
10
Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.类风湿关节炎患者与普通人群相比,五年内健康评估问卷残疾评分的变化。
Arthritis Rheum. 2006 Oct;54(10):3113-8. doi: 10.1002/art.22130.

引用本文的文献

1
Pain management in people with inflammatory arthritis: British Society for Rheumatology guideline scope.炎症性关节炎患者的疼痛管理:英国风湿病学会指南范围
Rheumatol Adv Pract. 2024 Nov 19;8(4):rkae128. doi: 10.1093/rap/rkae128. eCollection 2024.
2
Correlation between Quality of Life and Erythrocyte Sedimentation Rate with Disease Activity in Rheumatoid Arthritis.类风湿关节炎患者生活质量与红细胞沉降率和疾病活动度的相关性。
Curr Rheumatol Rev. 2024;20(5):563-568. doi: 10.2174/0115733971276855231208103527.
3
Is symptom duration before DMARD therapy a determinant of direct and indirect costs in DMARD-naïve RA patients? A systematic review.
在初治类风湿关节炎患者中,使用改善病情抗风湿药(DMARD)治疗前的症状持续时间是否是直接和间接成本的决定因素?一项系统评价。
Rheumatol Adv Pract. 2023 Apr 13;7(2):rkad040. doi: 10.1093/rap/rkad040. eCollection 2023.
4
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials.奥扎鲁单抗,一种抗 TNFα NANOBODY 化合物,在类风湿关节炎患者中的疗效和药代动力学:OHZORA 和 NATSUZORA 试验的 52 周结果。
Arthritis Res Ther. 2023 Apr 13;25(1):60. doi: 10.1186/s13075-023-03036-4.
5
Work Ability and Quality of Life in Patients with Rheumatoid Arthritis.类风湿关节炎患者的工作能力和生活质量。
Int J Environ Res Public Health. 2022 Oct 14;19(20):13260. doi: 10.3390/ijerph192013260.
6
A Decreased Absolute Number of T Cells in Patients with Active Rheumatoid Arthritis is Associated with Elevated Serum Osteopontin Levels with Disease Progression.活动期类风湿关节炎患者 T 细胞绝对数减少与疾病进展时血清骨桥蛋白水平升高相关。
Adv Ther. 2022 Jul;39(7):3280-3291. doi: 10.1007/s12325-022-02171-9. Epub 2022 May 23.
7
Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).患者满意度、偏好、期望、特征以及类风湿关节炎控制不佳的影响:一项大型国际队列研究(SENSE)中日本患者的亚组分析。
PLoS One. 2021 Nov 15;16(11):e0259389. doi: 10.1371/journal.pone.0259389. eCollection 2021.
8
Characterizing Long-Term Trajectories of Work and Disability Leave: The Role of Occupational Exposures, Health, and Personal Demographics.描述工作和残疾假的长期轨迹:职业暴露、健康和个人人口统计学的作用。
J Occup Environ Med. 2019 Nov;61(11):936-943. doi: 10.1097/JOM.0000000000001705.
9
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.类风湿关节炎前临床阶段用阿巴西普预防关节炎(APIPPRA 研究):一项多中心、随机、双盲、平行分组、安慰剂对照临床试验方案。
Trials. 2019 Jul 15;20(1):429. doi: 10.1186/s13063-019-3403-7.
10
Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis.载有泼尼松龙和甲氨蝶呤的叶酸偶联双层脂质体用于靶向类风湿关节炎。
Pharm Res. 2019 Jun 19;36(8):123. doi: 10.1007/s11095-019-2653-0.